Clinical trials
Completed Thrombosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
538 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 9 |
| 2003 | 8 |
| 2004 | 14 |
| 2005 | 19 |
| 2006 | 22 |
| 2007 | 18 |
| 2008 | 23 |
| 2009 | 26 |
| 2010 | 22 |
| 2011 | 19 |
| 2012 | 30 |
| 2013 | 21 |
| 2014 | 26 |
| 2015 | 31 |
| 2016 | 24 |
| 2017 | 32 |
| 2018 | 22 |
| 2019 | 32 |
| 2020 | 39 |
| 2021 | 22 |
| 2022 | 21 |
| 2023 | 16 |
| 2024 | 10 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 538 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 19 |
| HemoSonics LLC | 18 |
| Bayer | 10 |
| University of Edinburgh | 9 |
| Assistance Publique - Hôpitaux de Paris | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 8 |
| ARCA Biopharma, Inc. | 7 |
| Brigham and Women's Hospital | 7 |
| University Hospital, Ghent | 7 |
| Boston Scientific Corporation | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 538 |
| Venous Thrombosis | 55 |
| Hemorrhage | 46 |
| Cardiovascular Diseases | 37 |
| Venous Thromboembolism | 37 |
| Pulmonary Embolism | 36 |
| Stroke | 35 |
| Thromboembolism | 32 |
| Inflammation | 31 |
| Myocardial Infarction | 25 |
Trials
Showing 51 to 75 of 538. Each trial links to its page on Pharma Observatory.
438 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.